Literature DB >> 15353639

Neutron spectra in a tissue equivalent phantom during photon radiotherapy treatment by LINACS.

A Zanini1, E Durisi, F Fasolo, L Visca, C Ongaro, U Nastasi, K W Burn, J R M Annand.   

Abstract

Bremsstrahlung photon beams produced by LINAC accelerators are currently the most used radiotherapy method for tumour treatments. When the photon energy exceeds the (gamma,n) reaction threshold energy, the patient receives an undesired dose due to photoneutron production both in the accelerator head and in the human body. In this paper, a method is presented for the assessment of the photoneutron spectra produced by Giant Dipole Resonance (GDR) during cancer radiotherapy with energetic photon beams. Experimental and numerical results have been obtained for the facility at Onkologik Klinik, Lund (Sweden), which is based on an ELEKTA 18 MV LINAC. Neutron spectra are evaluated both at the patient plane and inside an anthropomorphic phantom.

Entities:  

Mesh:

Year:  2004        PMID: 15353639     DOI: 10.1093/rpd/nch205

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  3 in total

1.  Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy.

Authors:  Stephen F Kry; Rebecca M Howell; Mohammad Salehpour; David S Followill
Journal:  Med Phys       Date:  2009-04       Impact factor: 4.071

2.  Breakthrough whole body energy-specific and tissue-specific photoneutron dosimetry by novel miniature neutron dosimeter/spectrometer.

Authors:  Mehdi Sohrabi; Morteza Ebrahimzadeh Torkamani
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

3.  Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.

Authors:  Soheil Elmtalab; Iraj Abedi; Zahra Alirezaei; Mohammad Hossein Choopan Dastjerdi; Ghazale Geraily; Amir Hossein Karimi
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.